http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1473574-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af2fa4c994bee7e2259a66dfb09e7682 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 1974-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1977-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1473574-A |
| titleOfInvention | Sitosterol esters |
| abstract | 1473574 Sitosterol ester LABORATORIOS FERRER SL 8 May 1974 [8 May 1973] 20241/74 Heading C2U The invention comprises #-sitosteryl 2-(#- chlorophenoxy)-2-methylpropionate and its preparation from #-sitosterol by esterification with clofibric acid or a functional derivative thereof. Anti-hyperlipemic and anti-hypercholesterolemic compositions for oral administration comprise a carrier and the compound of the invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5892068-A |
| priorityDate | 1973-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.